Rishi Bedi leads engineering and product development at Y-Trap, a biotechnology company focused on the development of revolutionary technologies for cancer immunotherapy. He’s applied machine learning for predicting the structure of protein-protein complexes (at Stanford with Ron Dror), antibody engineering (in collaboration with Distributed Bio), assessment of neurodegenerative disease progression (at Novartis), and phenotypic drug discovery for neuropsychiatric disorders (at System1 Biosciences).